Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27797962.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In inflammation-associated progressive neuroinflammatory disorders, such as multiple sclerosis (MS), inflammatory infiltrates containing T helper 1 (T<sub>H</sub>1) and T<sub>H</sub>17 cells cause demyelination and neuronal degeneration. Regulatory T cells (T<sub>reg</sub>) control the activation and infiltration of autoreactive T cells into the central nervous system (CNS). In MS and experimental autoimmune encephalomyelitis (EAE) in mice, T<sub>reg</sub> function is impaired. We show that a recently approved drug, Nle<sup>4</sup>-d-Phe<sup>7</sup>-α-melanocyte-stimulating hormone (NDP-MSH), induced functional T<sub>reg</sub>, resulting in amelioration of EAE progression in mice. NDP-MSH also prevented immune cell infiltration into the CNS by restoring the integrity of the blood-brain barrier. NDP-MSH exerted long-lasting neuroprotective effects in mice with EAE and prevented excitotoxic death and reestablished action potential firing in mouse and human neurons in vitro. Neuroprotection by NDP-MSH was mediated via signaling through the melanocortin-1 and orphan nuclear 4 receptors in mouse and human neurons. NDP-MSH may be of benefit in treating neuroinflammatory diseases such as relapsing-remitting MS and related disorders.
Medical subject headings
- Encephalomyelitis, Autoimmune, Experimental
- Neuroprotective Agents
- Receptor, Melanocortin, Type 1
- alpha-MSH